High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

Muzaffar H. Qazilbash,Marcel P. Devetten,Jame Abraham,Joseph P. Lynch,Charles L. Beall,Miklos Auber,Robin Weisenborn,Pam Bunner,Solveig G. Ericson

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

2003

Muzaffar H. Qazilbash
Marcel P. Devetten
Jame Abraham
Joseph P. Lynch
Charles L. Beall
Miklos Auber
Robin Weisenborn
Pam Bunner
Solveig G. Ericson

We evaluated the results of high-dose therapy (HDT) and autologous hematopoietic stem cell transplantation (ASCT) in patients with relapsed or primary refractory Hodgkin’s disease (HD), using a previo

Keywords:

Lymphoma
Medicine
Refractory
Hematopoietic stem cell transplantation
Immunology
Stem cell
Progression-free survival
Autologous stem-cell transplantation
Chemotherapy
Salvage therapy
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations